Thyrocare Q2 Profit Slips 68% YoY To ₹15 Cr Due To ₹45 Cr Exceptional Expense

by · Inc42

SUMMARY

  • Thyrocare’s consolidated net profit fell 68.2% YoY to ₹15.2 Cr, while revenue from operations grew 25.1% to ₹270.8 Cr.
  • The diagnostics company recognised a ₹45 Cr impairment loss on its investment in Nueclear Healthcare, which it has proposed to sell for around ₹141.4 Cr.
  • Without the impairment charge, Thyrocare’s profit before tax spiked about 25% YoY to ₹77.8 Cr and reported EBITDA stood at ₹89.3 Cr.